BioCentury
ARTICLE | Financial News

NanoViricides financial update

March 4, 2013 8:00 AM UTC

NanoViricides retired its remaining 1,826 shares of series C convertible preferred stock sold to Seaside 88 for $2 million, including accrued dividends of $6,002.45 and a 10% redemption premium. Seasi...